Related Experiment Video

Updated: Aug 15, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Transcription inhibition: a potential strategy for cancer therapeutics

Frederick A Derheimer1, Ching-Wei Chang, Mats Ljungman

  • 1Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.

European Journal of Cancer (Oxford, England : 1990)
|October 11, 2005
PubMed

Insights

Transcription interference triggers cellular stress, activating tumor suppressor p53. If unresolved, cells undergo apoptosis, a process potentially exploitable for anti-cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Therapeutics

Background:

  • Transcription interference activates cellular stress responses.
  • This stress response involves the induction of the tumor suppressor p53.
  • Unresolved transcription blockage can lead to apoptosis, a programmed cell death.

Purpose of the Study:

  • To investigate the mechanisms linking transcription interference to apoptosis.
  • To explore the role of p53 in transcription-induced apoptosis.
  • To evaluate the potential of transcription interference as an anti-cancer strategy.

Main Methods:

  • Cellular stress induction models.
  • Analysis of p53 pathway activation.
  • Apoptosis assays (p53-dependent and independent).
  • Investigation of molecular mechanisms (protein levels, subcellular localization).

Main Results:

  • Transcription interference robustly induces a cellular stress response and p53.
  • Cells undergo apoptosis if transcription is not restored, via p53-dependent and independent pathways.
  • Potential mechanisms include altered anti-apoptotic factor levels, nuclear protein accumulation, and mitochondrial p53 accumulation.
  • Chemotherapeutic agents interfering with transcription demonstrate anti-cancer activity.

Conclusions:

  • Transcription interference is a potent trigger for apoptosis.
  • The p53 pathway plays a significant role in this process.
  • Understanding these mechanisms could lead to novel anti-cancer therapeutic strategies targeting transcription.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...